GlobalCapital Data
Asset Backed Monitor (ABM)
Critical securitization data, backed by independent editorial insight and market intelligence.
GlobalCapital Data
Asset Backed Monitor (ABM)
Critical securitization data, backed by independent editorial insight and market intelligence.
To find out more about ABM or to book your demo, contact our sales team
Overview
Asset Backed Monitor goes beyond pure data, delivering verified European securitization issuance backed by independent editorial insight and market colour. Built on GlobalCapital’s trusted and independent voice in securitization.
Centralising critical securitization data in one intuitive, searchable database, tracking structures, counterparties and pricing terms.
✔ ABS, RMBS, CMBS, CLO and private deal data
✔ Seamlessly switch between deal and tranche view
✔ Who arranged the deal, risk retention holders, and how it was structured
✔ Easily find the legal advisers on each deal
✔ Market sentiment: quotes from issuers, arrangers, and investors
✔ Who’s winning mandates by volume, deal count and asset class
Benefits
Verified data. Editorially sourced. Built for active workflows.
Unlike pure data providers, we provide market-leading securitization data with independent reporting and analysis drawn directly from issuers, investors and banks, supported by a library of 1,000+ annual articles.
Time-saving, accurate & efficient
Verified deal intelligence across ABS, RMBS, CMBS and CLOs, with 30 datapoints of searchable, filterable analytics backed by market colour and sentiment.
Independent editorial analysis
Go beyond the data with deeper editorial analysis and market context from our editorial team, delivered through articles that capture how issuers, investors and banks are responding to deals.
Compare, benchmark & monitor
ABM helps issuers, investment banks, and investors act with confidence. Validate market positioning, track mandates with customisable league tables, and screen issuance across asset classes and geographies.
League tables
Custom league tables for your pitch books, showing who’s winning mandates by volume, deal count, and sector.
Securitization data backed by our editorial coverage
-
Harben is backed by Bradford & Bingley mortgages, Avon by GMAC and Platform Home Loans mortgages -
Deal refinances three banks' loans for $1.3bn acquisition
-
Select group of triple-A buyers hold significant pricing power
Features
✔ Comprehensive deal data
Verified deal intelligence across ABS, RMBS, CMBS and CLOs, with 30 datapoints of searchable, filterable analytics backed by market colour and sentiment.
✔ Customisable league tables
Filter and rank by asset class, currency, and arranger to track market activity, support pitch books, and showcase expertise to clients.
✔ Deal adviser intelligence
Identify legal advisers, arrangers, and service providers on every deal, track issuer and arranger activity over time, and uncover gaps in coverage across sectors or issuers.
✔ Backed by editorial coverage & market colour
Gain deeper insight into each securitization deal through our editorial reporting and analysisdrawn directly from issuers, investors and banks, supported by a library of 1,000+ annual articles.
USERS
USE CASES
ISSUERS
CLO Managers, Heads of Treasury, Treasury Teams, Heads of Capital Markets, CFOs, Funding Managers, Managing Directors, Capital Markets, Heads of Structured Finance, Treasury Analysts, Finance Directors.
- Identify leading arrangers and service providers
- Validate market positioning with independent coverage
- Identify legal advisers on each transaction
INVESTMENT BANKS
Structured Products (ABS, RMBS, CMBS, CLO’s, Syndicate Teams, Origination Teams, Structured Finance, Analysts, Associates, Structured Credit Analysts.
- Monitor your position in the market with customisable league tables
- Identify gaps in issuer or sector coverage
INVESTOR &
ASSET MANAGERS
Portfolio Managers, Directors, Structured Finance Teams, Asset Managers, Securitized Portfolio Managers, Chief Investment Officers.
- Monitor issuer and arranger activity over time
- Track new issuance and market sentiment to inform portfolio strategy and spot emerging trends.
LAW FIRMS
Partners, Counsels, Legal Directors, Senior Associates, Structured Finance Teams, Capital Markets Lawyers, Banking & Finance Lawyers.
- Benchmark against peers to showcase expertise and track competitive positioning
- Identify issuers, arrangers, and investors active in the market to target potential clients and pitch mandates
Data backed by independent editorial coverage and market colour
Unlike pure data providers, we provide market-leading securitization data with independent reporting and analysis drawn directly from issuers, investors and banks, supported by a library of 1,000+ annual articles.
✔ Identify structural features: innovations, market firsts, and key differentiators
✔ Benchmark within market context: compares to recent deals and leading players
✔ Market sentiment: quotes from issuers, arrangers, and investors
✔ Outline target investors and objectives: strategic rationale for the issuance
✔ Analyse reception and resilience: performance under varying market condition
✔ Dig into the latest regulatory updates: expert coverage on securitization regulation, capital requirements solvency
-
European CLO investors are targeting mezzanine and junior tranches of US and European deals, as wide spreads further down the capital stack lag the aggressive tightening seen in senior paper.
-
Obvion priced its €2bn Storm 2017-1 RMBS at a record low spread for for five year Dutch RMBS paper since the financial crisis, and the lender has said it will continue to look to build on its range of RMBS transactions.
-
Carlyle released price guidance for the refinancing of its Carlyle Global Market Strategies Euro CLO 2014-2 on Monday, as the primary CLO pipeline takes a back seat to a wave of refinancing deals.
-
The latest figures from the Mortgage Bankers Association show a small increase in mortgage applications during the first week of January, but year over year volume is down sharply.
-
The European ABS market is riding a wave of what market participants describe as “mass bullishness” that is encouraging opportunistic sellers to securitize legacy assets, some of which date back to before the credit crisis. David Bell reports.
-
The pharmaceuticals industry is back under the microscope of US CLO players after comments on drug pricing from president-elect Donald Trump hinted at a tougher environment for drug makers under a Trump presidency.
Gain a competitive advantage with our capital markets databases covering the public and private markets.
Request a demo
Centralising critical securitization data in one intuitive, searchable database, tracking structures, counterparties and pricing terms. Built on GlobalCapital’s trusted and independent voice in securitization.
✔ Seamlessly switch between deal and tranche view
✔ Who arranged the deal, risk retention holders, and how it was structured
✔ Easily find the legal advisers on each deal
✔ Market sentiment: quotes from issuers, arrangers, and investors
✔ Who’s winning mandates by volume, deal count and asset class
Request a demo to find out more about Asset Backed Monitor and how it can be embedded into your daily workflow.